MSI2 and hepatocellular carcinoma: Musashi-2 (MSI2) upregulates the expression of the “self-renewal gene” Lin28A in LCSCs, thereby increasing the levels of the pluripotency factors NANOG, OCT-4, and SOX2 to promote sorafenib resistance in HCC [90].